Skip to content

Abnormal Circulating Phosphate Ion Concentration C4022032

Published: July 22, 2026Updated: August 20, 2026

A condition where blood phosphate levels are too high or too low. Phosphate is important for bones, muscles, and energy use. Treatment involves finding and fixing the underlying cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Irregular heartbeat

Abnormal heart rhythms (arrhythmias) including atrial fibrillation or ventricular irritability due to disrupted electrolyte balance affecting cardiac conduction.

Seek immediate emergency care for palpitations, chest pain, or feeling faint

!

Difficulty breathing

Shortness of breath and respiratory muscle weakness that can progress to respiratory failure in severe cases.

Seek immediate emergency care for any difficulty breathing or bluish lips/fingernails

Fatigue and weakness

(constitutional)

Persistent tiredness and generalized muscle weakness due to impaired energy metabolism from phosphate imbalance affecting ATP production.

Frequency: 70-85% of patients

Muscle weakness

(musculoskeletal)

Progressive muscle weakness particularly in the proximal muscles of the thighs and shoulders, making it difficult to rise from a chair or lift arms.

Frequency: 65-80% of patients

Loss of appetite and nausea

(gastrointestinal)

Decreased appetite accompanied by feelings of nausea, which may progress to vomiting in more severe cases.

Frequency: 40-55% of patients

Confusion and mental status changes

(neurologic)

Difficulty concentrating, mental confusion, and in severe cases, disorientation or altered consciousness.

Frequency: 30-45% of patients

Bone pain

(musculoskeletal)

Deep bone pain, particularly in the lower back, hips, and legs, resulting from altered calcium-phosphate metabolism in bone tissue.

Frequency: 35-50% of patients

Itchy skin

(dermatologic)

Generalized pruritus (itching) especially on the arms and legs, more commonly associated with elevated phosphate levels.

Frequency: 15-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Phosphate supplementation

Oral phosphate replacement therapy for hypophosphatemia using phosphate salts to restore normal serum levels and support cellular energy metabolism.

medication
3

Phosphate binders

For hyperphosphatemia, phosphate-binding agents that reduce intestinal phosphate absorption, commonly used in chronic kidney disease.

medication

Additional treatment options

Phosphate-adjusted diet

Individualized dietary phosphorus modification, either increasing intake through phosphate-rich foods or restricting phosphorus according to the specific disorder.

dietary

Serial phosphate level monitoring

Regular serum phosphate measurements to guide treatment adjustments and prevent complications from over- or under-correction.

monitoring

Dialysis for refractory cases

When phosphate disorders are secondary to renal failure and unresponsive to medical management, dialysis provides phosphate clearance.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Phosphate Ion Concentration C4022032?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1-59.

guideline2017View source →
2

Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol. 2015;10(7):1257-1272.

review2015View source →
3

National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1-201.

guideline2003View source →
4

Weinman EJ, Shenolikar S, Subramanya SB. Molecular mechanisms of renal phosphate handling. Curr Opin Nephrol Hypertens. 2020;29(4):417-424.

review2020View source →
5

Isakova T, Xie H, Yang W, et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011;305(23):2432-2439.

clinical_trial2011View source →
6

Foster JR, Morrison G. Disorders of calcium, phosphorus, and magnesium. In: Brenner and Rector's The Kidney, 11th ed. Elsevier; 2019:Chapter 15.

textbook2019
7

Hruska KA, Mathew S, Davies MR, Khosravi M. Chronic kidney disease mineral bone disorder: A model for renal osteodystrophy. Kidney Int. 2021;99(1):34-47.

position_statement2021View source →
8

Shigematsu T, Topic A, Group F. Hyperphosphatemia in chronic kidney disease. Kidney Res Clin Pract. 2022;41(3):269-278.

review2022View source →
9

Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis. JAMA. 2011;305(11):1119-1127.

meta_analysis2011View source →
10

Moe SM, Drüeke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69(11):1945-1953.

consensus2006View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Phosphate Ion Concentration C4022032. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy